Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM120A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | NTMT1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | SETD4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | MRPS35 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | SGF29 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | TMPO | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | PRRC2B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | CSNK1G2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | EFCAB7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ZNF398 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |